Literature DB >> 25666435

Variants of unknown significance on chromosomal microarray analysis: parental perspectives.

Stephanie Jez1, Megan Martin2, Sarah South1,3, Rena Vanzo2, Erin Rothwell4.   

Abstract

Chromosomal microarray is the recommended first-tier genetic test when a child presents with idiopathic developmental delay (DD), intellectual disability (ID), and/or autism spectrum disorder (ASD). Microarray may discover variants of unknown clinical significance (VUS) and been suggested to cause parental stress and anxiety. A retrospective, mixed methods study investigated parental perceptions of chromosomal microarray results that contain VUS. Surveys were sent to parents of children with DD/ID/ASD following a VUS result to seek information regarding parental understanding of the result, perceived value, and perceptions of child vulnerability and parental stress. Parents reported that chromosomal microarray was important for understanding their child's diagnosis and they were satisfied with the information. A majority of parents reported high confidence in their ability to explain a VUS result to others. Of the parents who reported they received support, many reported that the support was from a genetic counselor. Based on these results, VUS results are important to parents of children with DD/ID/ASD and genetic counseling regarding VUS results contributes positively to both parental understanding and support.

Entities:  

Keywords:  Autism spectrum disorder; Chromosomal microarray analysis; Developmental delay; Intellectual disability; Variant of unknown significance

Year:  2015        PMID: 25666435      PMCID: PMC4567987          DOI: 10.1007/s12687-015-0218-4

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  13 in total

1.  Psychological issues in genetic testing for inherited cardiovascular diseases.

Authors:  Rajani D Aatre; Sharlene M Day
Journal:  Circ Cardiovasc Genet       Date:  2011-02

Review 2.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

3.  American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants.

Authors:  Hutton M Kearney; Erik C Thorland; Kerry K Brown; Fabiola Quintero-Rivera; Sarah T South
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

4.  Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

Authors:  Suzanne C O'Neill; Christine Rini; Rachel E Goldsmith; Heiddis Valdimarsdottir; Lawrence H Cohen; Marc D Schwartz
Journal:  Psychooncology       Date:  2009-10       Impact factor: 3.894

5.  The child vulnerability scale: an instrument to measure parental perceptions of child vulnerability.

Authors:  B W Forsyth; S M Horwitz; J M Leventhal; J Burger; P J Leaf
Journal:  J Pediatr Psychol       Date:  1996-02

6.  Parental perceived value of a diagnosis for intellectual disability (ID): a qualitative comparison of families with and without a diagnosis for their child's ID.

Authors:  Nancy L Makela; Patricia H Birch; Jan M Friedman; Carlo A Marra
Journal:  Am J Med Genet A       Date:  2009-11       Impact factor: 2.802

7.  A place for genetic uncertainty: parents valuing an unknown in the meaning of disease.

Authors:  Ian Whitmarsh; Arlene M Davis; Debra Skinner; Donald B Bailey
Journal:  Soc Sci Med       Date:  2007-06-11       Impact factor: 4.634

8.  Variability in interpreting and reporting copy number changes detected by array-based technology in clinical laboratories.

Authors:  Karen D Tsuchiya; Lisa G Shaffer; Swaroop Aradhya; Julie M Gastier-Foster; Ankita Patel; M Katharine Rudd; Julie Sanford Biggerstaff; Warren G Sanger; Stuart Schwartz; James H Tepperberg; Erik C Thorland; Beth A Torchia; Arthur R Brothman
Journal:  Genet Med       Date:  2009-12       Impact factor: 8.822

9.  Chromosomal microarray testing influences medical management.

Authors:  Michael E Coulter; David T Miller; David J Harris; Pamela Hawley; Jonathan Picker; Amy E Roberts; Magdi M Sobeih; Mira Irons
Journal:  Genet Med       Date:  2011-09       Impact factor: 8.822

10.  "What does it mean?": uncertainties in understanding results of chromosomal microarray testing.

Authors:  Marian Reiff; Barbara A Bernhardt; Surabhi Mulchandani; Danielle Soucier; Diana Cornell; Reed E Pyeritz; Nancy B Spinner
Journal:  Genet Med       Date:  2012-01-05       Impact factor: 8.822

View more
  12 in total

1.  Impacts of variants of uncertain significance on parental perceptions of children after prenatal chromosome microarray testing.

Authors:  Preeya Desai; Hannah Haber; Jessica Bulafka; Amita Russell; Rebecca Clifton; Julia Zachary; Seonjoo Lee; Tianshu Feng; Ronald Wapner; Catherine Monk; Wendy K Chung
Journal:  Prenat Diagn       Date:  2018-07-24       Impact factor: 3.050

2.  Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy.

Authors:  Charlotte Burns; Laura Yeates; Catherine Spinks; Christopher Semsarian; Jodie Ingles
Journal:  Eur J Hum Genet       Date:  2017-05-03       Impact factor: 4.246

3.  Parents' Perspectives on Variants of Uncertain Significance from Chromosome Microarray Analysis.

Authors:  Lesli A Kiedrowski; Kailey M Owens; Beverly M Yashar; Jane L Schuette
Journal:  J Genet Couns       Date:  2015-05-19       Impact factor: 2.537

Review 4.  Patients' views on variants of uncertain significance across indications.

Authors:  Kristin Clift; Sarah Macklin; Colin Halverson; Jennifer B McCormick; Abd Moain Abu Dabrh; Stephanie Hines
Journal:  J Community Genet       Date:  2019-08-20

5.  Hope versus reality: Parent expectations of genomic testing.

Authors:  Katherine E Donohue; Siobhan M Dolan; Dana Watnick; Katie M Gallagher; Jacqueline A Odgis; Sabrina A Suckiel; Nehama Teitelman; Bruce D Gelb; Eimear E Kenny; Melissa P Wasserstein; Carol R Horowitz; Laurie J Bauman
Journal:  Patient Educ Couns       Date:  2021-01-29

6.  Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.

Authors:  Karen S Ho; Hope Twede; Rena Vanzo; Erin Harward; Charles H Hensel; Megan M Martin; Stephanie Page; Andreas Peiffer; Patricia Mowery-Rushton; Moises Serrano; E Robert Wassman
Journal:  Biomed Res Int       Date:  2016-11-16       Impact factor: 3.411

7.  "Possibly positive or certainly uncertain?": participants' responses to uncertain diagnostic results from exome sequencing.

Authors:  Debra Skinner; Myra I Roche; Karen E Weck; Kelly A Raspberry; A Katherine M Foreman; Natasha T Strande; Jonathan S Berg; James P Evans; Gail E Henderson
Journal:  Genet Med       Date:  2017-10-02       Impact factor: 8.822

8.  Analytical and Clinical Validity Study of FirstStepDx PLUS: A Chromosomal Microarray Optimized for Patients with Neurodevelopmental Conditions.

Authors:  Charles Hensel; Rena Vanzo; Megan Martin; Sean Dixon; Christophe Lambert; Brynn Levy; Lesa Nelson; Andy Peiffer; Karen S Ho; Patricia Rushton; Moises Serrano; Sarah South; Kenneth Ward; Edward Wassman
Journal:  PLoS Curr       Date:  2017-02-27

9.  Association between distress and knowledge among parents of autistic children.

Authors:  Afiqah Yusuf; Iskra Peltekova; Tal Savion-Lemieux; Jennifer Frei; Ruth Bruno; Ridha Joober; Jennifer Howe; Stephen W Scherer; Mayada Elsabbagh
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

10.  Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.

Authors:  Karen S Ho; E Robert Wassman; Adrianne L Baxter; Charles H Hensel; Megan M Martin; Aparna Prasad; Hope Twede; Rena J Vanzo; Merlin G Butler
Journal:  Int J Mol Sci       Date:  2016-12-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.